NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsidersSynopsys Inc. News Investing News, Analysis, and Tips Dec 5, 2024 1:55 PM EST Midday stock movers: Tesla, Dollar General, HP Enterprise, more Here are the stocks making the biggest market moves midday. TSLADG...
“股息历史记录”页面是一个单独页面,可查看所有汇总的股息支付信息。请访问我们的股息日历:我们的合作伙伴 Quotemedia 提供了下个月的除息日期。
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Synopsys Stock vs. The Competition TypeSynopsysComputer and Technology CompaniesS&P 500 Consensus Rating Score 3.00 2.58 2.49 Consensus Rating Buy Moderate Buy Hold Predicted Upside 13.27% Upside 109.48% Upside 11.52...
The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. The numbers next to the bi...
SNPS Stock USD 495.82 4.34 0.87% Synopsys volatility indicators tool provides the execution environment for running the Average True Range indicator and other technical functions against Synopsys. Synopsys value trend is the prevailing direction of the price over some defined period of time. The ...
Collagens are the most abundant proteins in the extra cellular matrix/ECM of human tissues that are encoded by different genes. There are single nucleotide polymorphisms/SNPs which are considered as the most useful biomarkers for some disease diagnosis or prognosis. The aim of this study is screen...
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Zacks Naming Top 10 Stocks for 2024 Want to be tipped off early to our 10 top picks for the entirety of 2024? History suggests their performance could be sensational. ...
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Synopsys...